Arovella Snaffles R&D Rebate Worth $3M for Cancer Cell Therapy Research

The Market HeraldOct 24 22:55 ET

Arovella Therapeutics Ltd: Arovella receives R&D tax rebate of $3.0 million

ASXOct 24 19:55 ET · Announcements

Arovella Therapeutics Forms Clinical Advisory Board to Advise on US FDA Filing

MT NewswiresOct 14 18:01 ET

Arovella Therapeutics Enhances Expertise for Upcoming Trials

TipRanksOct 13 21:07 ET

Arovella Therapeutics Ltd: Appendix 4E and Annual Report

Aug 21 19:43 ET · Announcements

Arovella Therapeutics Receives Positive Feedback From US FDA for Blood Cancer Treatment; Shares Jump 7%

MT NewswiresAug 6 21:32 ET